Cancer News and Research

Latest Cancer News and Research

Aspirin offers help for Barrett's esophagus

Researchers at Fred Hutchinson Cancer Research Center have found that people with the most-aggressive form of Barrett's esophagus, a precancerous condition that can lead to esophageal cancer, may benefit the most from preventive therapy with aspirin, ibuprofen and other nonsteroidal anti-inflammatory drugs, or NSAIDs.

27 Feb 2007

Influence of inflammatory polyarthritis on cancer incidence and survival

Patients with rheumatoid arthritis (RA), a chronic inflammatory autoimmune disease, have a high risk of death from disease - at least double the risk of the general population, studies overwhelmingly show. Evidence has been less clear on whether RA patients are exceptionally vulnerable to dying from cancer.

27 Feb 2007

High blood glucose levels may signal an increased risk for cancer in women

The March journal also includes a study that found a link between high levels of persistent organic pollutants (POPs) in a person's bloodstream and insulin resistance, a precursor for type 2 diabetes.

27 Feb 2007

Stimuvax investigational lung cancer vaccine phase III study starts

Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).

26 Feb 2007

Publication of the National Mesothelioma Framework

People with a chest cancer related to exposure to asbestos will receive a boost today, as a new framework for improving their care is launched by Britain's Health Minister Rosie Winterton.

From Asthma + Lung UK 26 Feb 2007

Financial interest of drug industry influences research results

According to the latest research breast cancer studies funded by drug companies are more likely to come up with positive findings than those without pharmaceutical industry backing.

26 Feb 2007

High exposure to secondhand smoke from cigarettes detected in Baltimore bars

Workers and patrons of Baltimore bars are exposed to high levels of secondhand smoke, according to two studies conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

26 Feb 2007

Quantum dots detect metastatic lesions

By injecting quantum dots into tumors, investigators at Carnegie Mellon University have been able to image sentinel lymph nodes in animals using near-infrared light. These results could lead to a simple, non-invasive method for detecting metastasis.

26 Feb 2007

siRNA delivery into human T cells and primary cells with carbon-nanotube transporters

Short pieces of RNA, known as small interfering RNA (siRNA), have the potential to become a new class of anticancer drugs if researchers can solve the problem of how to deliver these fragile molecules to cancer cells.

26 Feb 2007

Quantum rods and dots image cancer cells

Brightly fluorescent quantum dots and quantum rods are quickly becoming important tools for identifying specific molecules and cells in living systems. Two new reports demonstrate some of the ways in which cancer researchers are using these nanoscale imaging agents.

26 Feb 2007

Perfluorocarbon nanoparticles track living cells

Stem cell therapy, primarily bone marrow transplantation, plays a key role in treating leukemia and other types of cancer.

26 Feb 2007

Androgen deprivation therapy may increase risk of death from heart disease in older men

Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions.

26 Feb 2007

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

26 Feb 2007

Osteopenia and cancer in children and adolescents

Physicians caring for children with cancer should be on the lookout for signs of bone fragility caused by disease and treatment, according to a new report.

26 Feb 2007

Hormone patch could be safer than pills in relieving the symptoms of the menopause

According to new research by French scientists hormone skin patches and gels are far less likely than pills to cause dangerous blood clots.

26 Feb 2007

Breath test detects lung cancer

Scientists in the United States have come up with a breath test which can detect lung cancer in patients even when it is in the early stages of the disease.

26 Feb 2007

State actions on human papillomavirus vaccine proposals

The following highlights recent news of state actions on human papillomavirus vaccine proposals. Merck's HPV vaccine Gardasil and GlaxoSmithKline's HPV vaccine Cervarix in clinical trials have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases.

25 Feb 2007

Texas Gov. Perry says Merck campaign contribution had no effect on decision to mandate Gardasil

Texas Gov. Rick Perry (R) on Thursday said that contributions made by a Merck political action committee to his campaign had no influence on his decision to issue an executive order requiring that all girls entering the sixth grade receive a human papillomavirus vaccine, the AP/International Herald Tribune reports

25 Feb 2007

CDC says Gardasil's side effects minor

CDC officials on Thursday plan to present data at a meeting in Atlanta showing that 542 adverse health complaints have been reported about Merck's human papillomavirus vaccine Gardasil, but agency officials said the side effects of the vaccine are minor and that the vaccine does not require additional warning labels, the AP/Long Island Newsday reports .

25 Feb 2007

Pharmaceutical companies overcharging federal health care programs

Pharmaceutical companies have been systematically overcharging federal health care programs, costing taxpayers billions of dollars, according to federal officials, members of Congress and an advocacy group, the Newhouse News/Richmond Times-Dispatch reports.

25 Feb 2007